Showing results (1-10 of 181) with videos related to
Sort By:
Pageof 19
Journal of Neurovirology|February 26, 2004
Sequence heterogeneity and viral dynamics in cerebrospinal fluid and plasma during antiretroviral therapyDavid W HaasCurrent HIV/AIDS Reports|April 13, 2006
Human genetic variability and HIV treatment responseDavid W HaasTopics in HIV Medicine : a Publication of the International AIDS Society, USA|September 20, 2005
Will pharmacogenomic discoveries improve HIV therapeutics?David W HaasPerspectives on Sexual and Reproductive Health|September 7, 2002
The transition of adolescent males to first sexual intercourse: anticipated or delayed?Renata Forste, David W HaasClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 16, 2020
Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral RegimensDavid W Haas, Edward P AcostaCurrent Opinion in HIV and AIDS|January 8, 2015
Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbiditiesDavid W Haas, Philip E TarrSocial Science & Medicine (1982)|November 4, 2004
Maternal education and child nutritional status in Bolivia: finding the linksMichelle Bellessa Frost, Renata Forste, David W HaasPersonalized Medicine|February 27, 2013
Clinical perspectives on human genetic screening to prevent nevirapine toxicityDavid W Haas, Piroon Mootsikapun, Kiat Ruxrungtham, et al.Journal of Virology|June 16, 2005
Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cellsPatrick R Harrington, David W Haas, Kimberly Ritola, et al.The Journal of Infectious Diseases|May 12, 2007
Human genomic association studies: a primer for the infectious diseases specialistAlison A Motsinger, David W Haas, Todd Hulgan, et al.Pageof 19